2023 Q4 Form 10-K Financial Statement

#000077954423000044 Filed on December 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $47.49M $51.05M $184.8M
YoY Change 1.28% -4.07% 0.61%
Cost Of Revenue $12.07M $13.24M $49.62M
YoY Change -7.41% -10.17% -5.61%
Gross Profit $35.42M $37.81M $135.2M
YoY Change 4.63% -1.74% 3.1%
Gross Profit Margin 74.58% 74.06% 73.15%
Selling, General & Admin $26.63M $26.84M $102.2M
YoY Change 4.33% 3.06% 7.45%
% of Gross Profit 75.19% 70.99% 75.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.092M $1.059M $4.225M
YoY Change 3.8% 4.03% 0.76%
% of Gross Profit 3.08% 2.8% 3.13%
Operating Expenses $33.81M $34.17M $130.0M
YoY Change 4.28% 3.38% 7.24%
Operating Profit $1.603M $3.637M -$4.840M
YoY Change 12.57% -32.91% -149.07%
Interest Expense $171.0K $174.0K $1.239M
YoY Change -156.07% -40.21% 3.94%
% of Operating Profit 10.67% 4.78%
Other Income/Expense, Net $151.0K $26.00K -$582.0K
YoY Change 308.11% -29.73% -133.11%
Pretax Income $1.754M $3.505M -$5.422M
YoY Change 51.73% -46.1% -146.65%
Income Tax $158.0K $173.0K -$64.00K
% Of Pretax Income 9.01% 4.94%
Net Earnings $1.370M $3.195M -$5.928M
YoY Change 79.79% -39.2% -163.87%
Net Earnings / Revenue 2.89% 6.26% -3.21%
Basic Earnings Per Share $0.38 $0.89 -$1.65
Diluted Earnings Per Share $0.38 $0.88 -$1.65
COMMON SHARES
Basic Shares Outstanding 3.604M shares 3.601M shares 3.601M shares
Diluted Shares Outstanding 3.631M shares 3.641M shares 3.601M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.12M $13.99M $13.42M
YoY Change -57.41% -47.43% -52.86%
Cash & Equivalents $12.12M $13.99M $13.42M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $1.368M $1.762M $1.781M
YoY Change -58.56% -47.68% -46.05%
Inventory $2.972M $3.249M $3.093M
Prepaid Expenses
Receivables $4.632M $3.748M $3.313M
Other Receivables $306.0K $336.0K $328.0K
Total Short-Term Assets $21.40M $23.08M $21.93M
YoY Change -45.26% -40.83% -43.9%
LONG-TERM ASSETS
Property, Plant & Equipment $33.52M $34.63M $130.8M
YoY Change -3.34% -0.47% -4.13%
Goodwill $7.440M $17.44M
YoY Change -57.34% 0.0%
Intangibles $4.220M $4.220M
YoY Change 0.0% 0.0%
Long-Term Investments $6.518M $6.496M $6.507M
YoY Change 0.82% 0.64% 0.65%
Other Assets $2.161M $2.154M $5.899M
YoY Change -14.38% -15.66% 4.56%
Total Long-Term Assets $152.2M $163.9M $155.0M
YoY Change -10.73% 14.02% -9.04%
TOTAL ASSETS
Total Short-Term Assets $21.40M $23.08M $21.93M
Total Long-Term Assets $152.2M $163.9M $155.0M
Total Assets $173.6M $187.0M $177.0M
YoY Change -17.17% 2.31% -15.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.573M $4.383M $4.058M
YoY Change 2.4% -18.73% -9.14%
Accrued Expenses $16.48M $16.22M $15.86M
YoY Change -10.0% -3.21% -13.4%
Deferred Revenue $3.418M $4.579M
YoY Change -38.24% -2.26%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.011M $1.983M $1.987M
YoY Change -69.41% -70.36% -69.78%
Total Short-Term Liabilities $26.48M $27.16M $27.86M
YoY Change -24.09% -18.97% -20.13%
LONG-TERM LIABILITIES
Long-Term Debt $4.649M $5.630M $5.140M
YoY Change -72.8% -69.06% -69.92%
Other Long-Term Liabilities $90.14M $91.25M $92.23M
YoY Change -7.49% 27.51% -5.35%
Total Long-Term Liabilities $94.79M $96.88M $97.37M
YoY Change -17.24% 7.93% -14.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.48M $27.16M $27.86M
Total Long-Term Liabilities $94.79M $96.88M $97.37M
Total Liabilities $121.3M $124.0M $126.7M
YoY Change -18.84% 0.61% -15.4%
SHAREHOLDERS EQUITY
Retained Earnings $36.79M $47.13M
YoY Change -16.91% 7.22%
Common Stock $14.97M $14.12M
YoY Change -3.63% -8.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.75M $61.25M $50.29M
YoY Change
Total Liabilities & Shareholders Equity $173.6M $187.0M $177.0M
YoY Change -17.17% 2.31% -15.55%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income $1.370M $3.195M -$5.928M
YoY Change 79.79% -39.2% -163.87%
Depreciation, Depletion And Amortization $1.092M $1.059M $4.225M
YoY Change 3.8% 4.03% 0.76%
Cash From Operating Activities $558.0K $4.761M $8.386M
YoY Change -87.63% -56.21% -58.79%
INVESTING ACTIVITIES
Capital Expenditures $276.0K $1.032M $3.857M
YoY Change -130.13% -261.5% 42.8%
Acquisitions
YoY Change
Other Investing Activities $22.00K $42.00K $5.133M
YoY Change -100.43% -193.33% -201.44%
Cash From Investing Activities -$254.0K -$990.0K $1.276M
YoY Change -95.76% 44.74% -116.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $531.0K
YoY Change -100.0% -66.2%
Cash From Financing Activities -$1.597M -7.675M -$19.69M
YoY Change -5.33% 260.5% 136.67%
NET CHANGE
Cash From Operating Activities $558.0K 4.761M $8.386M
Cash From Investing Activities -$254.0K -990.0K $1.276M
Cash From Financing Activities -$1.597M -7.675M -$19.69M
Net Change In Cash -$1.293M -3.904M -$10.02M
YoY Change -59.12% -148.44% -334.86%
FREE CASH FLOW
Cash From Operating Activities $558.0K $4.761M $8.386M
Capital Expenditures $276.0K $1.032M $3.857M
Free Cash Flow $282.0K $3.729M $4.529M
YoY Change -94.8% -67.61% -74.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000779544
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
1-09453
CY2023 dei Entity Registrant Name
EntityRegistrantName
ARK RESTAURANTS CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3156768
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
85 Fifth Avenue,
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
CY2023 dei City Area Code
CityAreaCode
212
CY2023 dei Local Phone Number
LocalPhoneNumber
206-8800
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
ARKR
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
41193011 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3604157 shares
CY2023 dei Auditor Name
AuditorName
CohnReznick LLP
CY2023 dei Auditor Firm
AuditorFirmId
596
CY2023 dei Auditor Location
AuditorLocation
Melville, New York
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13415000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23439000 usd
CY2023Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 usd
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
5021000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3313000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3185000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
328000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
440000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3093000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3707000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
212000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1778000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1569000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1523000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
21930000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
39093000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34314000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34682000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
96459000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
101720000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
7440000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17440000 usd
CY2023Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
4220000 usd
CY2022Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
4220000 usd
CY2023Q3 arkr Intangible Assets Net
IntangibleAssetsNet
187000 usd
CY2022Q4 arkr Intangible Assets Net
IntangibleAssetsNet
272000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3738000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3118000 usd
CY2023Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
6507000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
6465000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2161000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2524000 usd
CY2023Q3 us-gaap Assets
Assets
176956000 usd
CY2022Q4 us-gaap Assets
Assets
209534000 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4058000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4466000 usd
CY2023Q3 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
13829000 usd
CY2022Q4 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
16312000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7988000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7530000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1987000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
6575000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27862000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34883000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
92232000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97444000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5140000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
17089000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
125234000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
149416000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3604000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3604000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3600000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3600000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14161000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15493000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36091000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
44271000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
50288000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
59800000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
1434000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
318000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51722000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60118000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176956000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
209534000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184793000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
183674000 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
60000000 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
23498000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12407000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12936000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4310000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4297000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
189633000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
173810000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-4840000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
9864000 usd
CY2023 us-gaap Interest Expense
InterestExpense
1239000 usd
CY2022 us-gaap Interest Expense
InterestExpense
1192000 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
333000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
109000 usd
CY2023 us-gaap Other Income
OtherIncome
52000 usd
CY2022 us-gaap Other Income
OtherIncome
421000 usd
CY2023 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2022 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
2420000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-582000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1758000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5422000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11622000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-64000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1448000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5358000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
10174000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
570000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
893000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-5928000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
9281000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.65
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.61
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.65
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.58
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3601000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3556000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3601000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3603000 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51452000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
703000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
298000 usd
CY2022 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1615000 usd
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
894000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60118000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5358000 usd
CY2023 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
0 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
314000 usd
CY2023 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1139000 usd
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.625
CY2023 us-gaap Dividends Common Stock
DividendsCommonStock
2252000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51722000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5358000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
10174000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
314000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
298000 usd
CY2023 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2022 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
2420000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-620000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
582000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4310000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4297000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
507000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
873000 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
63000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
48000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
128000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-928000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-614000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
197000 usd
CY2023 arkr Increase Decrease In Prepaid And Accrued Income Taxes
IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes
-1566000 usd
CY2022 arkr Increase Decrease In Prepaid And Accrued Income Taxes
IncreaseDecreaseInPrepaidAndAccruedIncomeTaxes
-2118000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
46000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1682000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-363000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
254000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-408000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-420000 usd
CY2023 arkr Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-2477000 usd
CY2022 arkr Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
2699000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8386000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20347000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3857000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2701000 usd
CY2023 arkr Loans And Advances Made To Employees
LoansAndAdvancesMadeToEmployees
71000 usd
CY2022 arkr Loans And Advances Made To Employees
LoansAndAdvancesMadeToEmployees
229000 usd
CY2023 arkr Payments Received On Employee Receivables
PaymentsReceivedOnEmployeeReceivables
183000 usd
CY2022 arkr Payments Received On Employee Receivables
PaymentsReceivedOnEmployeeReceivables
169000 usd
CY2023 arkr Payments To Acquire Certificates Of Deposit
PaymentsToAcquireCertificatesOfDeposit
0 usd
CY2022 arkr Payments To Acquire Certificates Of Deposit
PaymentsToAcquireCertificatesOfDeposit
5000000 usd
CY2023 arkr Proceeds From Maturity Of Certificate Of Deposit
ProceedsFromMaturityOfCertificateOfDeposit
5021000 usd
CY2022 arkr Proceeds From Maturity Of Certificate Of Deposit
ProceedsFromMaturityOfCertificateOfDeposit
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1276000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7761000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15803000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4941000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
531000 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1571000 usd
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2252000 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
894000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
39000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
703000 usd
CY2023 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1139000 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1615000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19686000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8318000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10024000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4268000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23439000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19171000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13415000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23439000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1291000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1119000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
345000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
826000 usd
CY2023 arkr Noncash Decrease In Noncontrolling Interest From Deconsolidation
NoncashDecreaseInNoncontrollingInterestFromDeconsolidation
1685000 usd
CY2022 arkr Noncash Decrease In Noncontrolling Interest From Deconsolidation
NoncashDecreaseInNoncontrollingInterestFromDeconsolidation
0 usd
CY2023 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — The Company's fiscal year ends on the Saturday nearest September 30. The fiscal years ended September 30, 2023 and October 1, 2022 both included 52 weeks.</span></div>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are used for, but are not limited to: (i) projected cash flows related to asset impairments, including goodwill and intangibles, (ii) income tax valuation allowances for deferred tax assets, (iii) allowances for potential bad debts on receivables, (iv) assumptions regarding discount rates related to lease accounting, (v) the useful lives and recoverability of our long-lived assets, such as fixed assets and intangibles, (vi) fair values of financial instruments, (vii) share-based compensation, (viii) estimates made in connection with acquisition purchase price allocations, (ix) uncertain tax positions, and (x) determining when investment impairments are other-than-temporary. The Company’s accounting estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The accounting estimates may change as new events occur, as more experience is acquired and as more information is obtained. The Company evaluates and updates assumptions and estimates on an ongoing basis and may use outside experts to assist in the Company’s evaluation, as considered necessary. Actual results could differ from those estimates.
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101853000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company reduces credit risk by placing its cash and cash equivalents with major financial institutions with high credit ratings. At times, such amounts may exceed federally insured limits. Accounts receivable are primarily comprised of normal business receivables, such as credit card receivables, that are collected in a short period of time and amounts due from the hotel operators where the Company has a location, and are recorded upon satisfaction of the performance obligation. The Company reviews the collectability of its receivables on an ongoing basis, and has not provided for an allowance as it considers all of the counterparties will be able to meet their obligations. The concentration of credit risk with respect to accounts receivable is generally limited due to the short payment terms extended by the Company and the number of customers comprising the Company’s customer base.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, the Company had accounts receivable balances due from one hotel operator totaling 52% of total accounts receivable. As of October 1, 2022, the Company had accounts receivable balances due from two hotel operators totaling 54% of total accounts receivable.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended September 30, 2023 and October 1, 2022, the Company made purchases from two vendors that accounted for 22% and 20% of total purchases, respectively.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, all debt outstanding, other than the note payable to the sellers of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Blue Moon Fish Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is with one lender (see Note 10 – Notes Payable).</span></div>
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
97996000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67539000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63314000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34314000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34682000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4225000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4193000 usd
CY2023Q3 arkr Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities
LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities
340000 usd
CY2022Q4 arkr Liability For Gift Cards Included In Accrued Expenses And Other Current Liabilities
LiabilityForGiftCardsIncludedInAccruedExpensesAndOtherCurrentLiabilities
309000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000000 usd
CY2023Q3 arkr Goodwill Impairment Loss Tax Deductible
GoodwillImpairmentLossTaxDeductible
8000000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2300000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
17440000 usd
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q3 arkr Number Of Vi Es With Primary Benefits
NumberOfVIEsWithPrimaryBenefits
3 entity
CY2023Q3 arkr Number Of Vi Es With Primary Benefits
NumberOfVIEsWithPrimaryBenefits
3 entity
CY2023Q3 arkr Operating Lease Payments Decrease
OperatingLeasePaymentsDecrease
0.19
CY2023Q3 arkr Lessee Operating Lease Notice To Vacate
LesseeOperatingLeaseNoticeToVacate
P12M
CY2023Q3 arkr Land And Building Gross
LandAndBuildingGross
18393000 usd
CY2022Q4 arkr Land And Building Gross
LandAndBuildingGross
18033000 usd
CY2023Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
44308000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43054000 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
39025000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
36554000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
127000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
355000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
17440000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
10000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
7440000 usd
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
10000000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023Q3 arkr Intangible Assets Gross Excluding Trade Marks And Goodwill
IntangibleAssetsGrossExcludingTradeMarksAndGoodwill
2628000 usd
CY2022Q4 arkr Intangible Assets Gross Excluding Trade Marks And Goodwill
IntangibleAssetsGrossExcludingTradeMarksAndGoodwill
2628000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2441000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2356000 usd
CY2023Q3 arkr Intangible Assets Net
IntangibleAssetsNet
187000 usd
CY2022Q4 arkr Intangible Assets Net
IntangibleAssetsNet
272000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
85000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
85000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
85000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
17000 usd
CY2023Q3 arkr Sales Tax Payable Current
SalesTaxPayableCurrent
765000 usd
CY2022Q4 arkr Sales Tax Payable Current
SalesTaxPayableCurrent
916000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4487000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5517000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5962000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5534000 usd
CY2023Q3 arkr Accrued Occupancy And Other Operating Expenses Current
AccruedOccupancyAndOtherOperatingExpensesCurrent
2615000 usd
CY2022Q4 arkr Accrued Occupancy And Other Operating Expenses Current
AccruedOccupancyAndOtherOperatingExpensesCurrent
4345000 usd
CY2023Q3 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
13829000 usd
CY2022Q4 arkr Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
16312000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
13672000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
10442000 usd
CY2023 arkr Occupancy Lease Cost
OccupancyLeaseCost
334000 usd
CY2022 arkr Occupancy Lease Cost
OccupancyLeaseCost
461000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
4184000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
6498000 usd
CY2023 us-gaap Lease Cost
LeaseCost
18190000 usd
CY2022 us-gaap Lease Cost
LeaseCost
17401000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
18669000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
14633000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3860000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
53530000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y10M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0625
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13941000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12881000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12143000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11960000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12057000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
79284000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
142266000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42046000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
100220000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
7222000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
23729000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1987000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
6575000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-95000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-65000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5140000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
17089000 usd
CY2023 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2022 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
2420000 usd
CY2023 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
6000 usd
CY2022 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
65000 usd
CY2023Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
304000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
63000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
542000 usd
CY2023Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2023Q3 arkr Lessee Operating Lease Number Of Renewal Terms
LesseeOperatingLeaseNumberOfRenewalTerms
1 option
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2018Q2 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
2 plaintiff
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
63750 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
500000 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.032
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.497
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.042
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
544125 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.63
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
596476 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.21
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
22500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.80
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3750 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.65
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
48851 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.40
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
69125 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
20.50
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
26000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
18.27
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
471250 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
413000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
544125 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.63
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
840000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
310125 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.21
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
207000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
302125 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.98
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
477500 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
477500 shares
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
314000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
298000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
228000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
471250 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.57
CY2023 arkr Sharebased Compensation Arrangement By Sharebased Payment Award Option Outstanding And Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingAndExercisableWeightedAverageRemainingContractualTerm
P5Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
310125 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.21
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2023 arkr Maximum Amount Of Compensation Paid Under Cash Bonus Plan
MaximumAmountOfCompensationPaidUnderCashBonusPlan
1000000 usd
CY2023 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
272000 usd
CY2022 arkr Paycheck Protection Program Loan Forgiveness Income
PaycheckProtectionProgramLoanForgivenessIncome
2420000 usd
CY2023 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
6000 usd
CY2022 arkr Paycheck Protection Program Loan Interest Forgiveness Income
PaycheckProtectionProgramLoanInterestForgivenessIncome
65000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
319000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
817000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
237000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
49000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
556000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
866000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-237000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
173000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-383000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
409000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-620000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
582000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-64000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1448000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1139000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2440000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-241000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
275000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
419000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 usd
CY2023 arkr Effective Income Tax Rate Reconciliation Paycheck Protection Program Income Loss Amount
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramIncomeLossAmount
57000 usd
CY2022 arkr Effective Income Tax Rate Reconciliation Paycheck Protection Program Income Loss Amount
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramIncomeLossAmount
432000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
961000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
998000 usd
CY2023 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
120000 usd
CY2022 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
188000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
49000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
22000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1866000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
149000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
120000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
180000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-64000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1448000 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
5170000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
5293000 usd
CY2023Q3 arkr Deferred Tax Asset Lease Liabilities
DeferredTaxAssetLeaseLiabilities
22072000 usd
CY2022Q4 arkr Deferred Tax Asset Lease Liabilities
DeferredTaxAssetLeaseLiabilities
22570000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
376000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
336000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2483000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2269000 usd
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
511000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
604000 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30612000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31072000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3273000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1407000 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
27339000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
29665000 usd
CY2023Q3 arkr Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
23065000 usd
CY2022Q4 arkr Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
25886000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
188000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
271000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
348000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
390000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
23601000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
26547000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3738000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3118000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3273000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1407000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1803000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
149000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
159000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
120000 usd
CY2023 arkr Unrecognized Tax Benefits Increases Resulting From Current And Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentAndPriorPeriodTaxPositions
26000 usd
CY2022 arkr Unrecognized Tax Benefits Increases Resulting From Current And Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentAndPriorPeriodTaxPositions
39000 usd
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
185000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
159000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3601000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3556000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
47000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3601000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3603000 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
471250 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
329125 shares
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1875
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1875

Files In Submission

Name View Source Status
arkr-20230930_cal.xml Edgar Link unprocessable
0000779544-23-000044-index-headers.html Edgar Link pending
0000779544-23-000044-index.html Edgar Link pending
0000779544-23-000044.txt Edgar Link pending
0000779544-23-000044-xbrl.zip Edgar Link pending
a32023exhibit21.htm Edgar Link pending
a42023exhibit23.htm Edgar Link pending
a52023exhibit311.htm Edgar Link pending
a62023exhibit312.htm Edgar Link pending
a72023exhibit32.htm Edgar Link pending
arkr-20230930.htm Edgar Link pending
arkr-20230930.xsd Edgar Link pending
arkr-20230930_g1.jpg Edgar Link pending
arkrestaurantscorp-incenti.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
arkr-20230930_def.xml Edgar Link unprocessable
arkr-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arkr-20230930_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arkr-20230930_lab.xml Edgar Link unprocessable